ABSTRACT
The level 3 autonomous driving function allows the driver to perform non-driving-related tasks such as watching movies or reading while the system manages the driving task. However, when a difficult situation arises, the driver is requested to return to the loop of control. This switching from driver to passenger then back to driver may modify the driving paradigm, potentially causing an out-of-the-loop state. We tested the hypothesis of a linear (progressive) impact of various autonomous driving durations: the longer the level 3 autonomous function is used, the poorer the driver's takeover performance. Fifty-two participants were divided into 4 groups, each group being assigned a specific period of autonomous driving (5, 15, 45, or 60 min), followed by a takeover request with a time budget of 8.3 s. Takeover performance was assessed over two successive drives via reaction times and manual driving metrics (trajectories). The initial hypothesis (linearity) was not confirmed: there was a nonlinear relationship between autonomous driving duration and takeover performance, with one duration (15 min) appearing safer overall and mixed performance within groups. Repetition induced a major change in performance during the second drive, indicating rapid adaptation to the situation. The non-driving-related task appears critical in several respects (dynamics, content, driver interest) to proper use of level 3 automation. All this supports previous research prompting reservations about the prospect of car driving becoming like train travel.
ABSTRACT
Perinatal arterial stroke is the most frequent form of cerebral infarction in children. Neonatal seizures are the most frequent symptom during the neonatal period. The current management of perinatal stroke is based on supportive care. It is currently unknown if treatment of the seizures modifies the outcome, and no clinical studies have focused on seizures during neonatal stroke. We studied the effect of phenobarbital and levetiracetam on an ischemic-reperfusion stroke model in P7 rats using prolonged electroencephalographic recordings and a histologic analysis of the brain (24h after injury). The following two types of epileptic events were observed: 1) bursts of high amplitude spikes during ischemia and the first hours of reperfusion and 2) organized seizures consisting in discharges of a 1-2Hz spike-and-wave. Both phenobarbital and levetiracetam decreased the total duration of the bursts of high amplitude spikes. Phenobarbital also delayed the start of seizures without changing the total duration of epileptic discharges. The markedly limited efficacy of the antiepileptic drugs studied in our neonatal stroke rat model is frequently observed in human neonatal seizures. Both drugs did not modify the stroke volume, which suggests that the modification of the quantity of bursts of high amplitude spikes does not influence the infarct size. In the absence of a reduction in seizure burden by the antiepileptic drugs, we increased the seizure burden and stroke volume by combining our neonatal stroke model with a lithium-pilocarpine-induced status epilepticus. Our data suggest that the reduction of burst of spikes did not influence the stroke volume. The presence of organized seizure with a pattern close to what is observed in human newborns seems related to the presence of the infarct. Further research is required to determine the relationship between seizure burden and infarct volume.
